Linden Thomas Advisory Services’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Linden Thomas Advisory Services's ELV Position: Q3 2026 in Review
Linden Thomas Advisory Services sold out of Elevance Health (ELV) in Q3 2026, closing a stake of 615 shares — an estimated $238K sold.
Linden Thomas Advisory Services first reported a position in ELV in Q4 2022 and held it in 14 quarters. The position peaked at $854K in Q1 2024. 717 funds tracked by Wall St. Rank hold ELV as of Q3 2026.
- Linden Thomas Advisory Services reported no remaining Elevance Health position as of Q3 2026 after selling out during the quarter.
- Linden Thomas Advisory Services sold 615 Elevance Health shares in Q3 2026, an estimated $238K.
- Linden Thomas Advisory Services first reported a position in Elevance Health in Q4 2022 and held it in 14 quarters.
- Linden Thomas Advisory Services's Elevance Health position peaked at $854K in Q1 2024.
- 717 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.
Based on Linden Thomas Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.